Free Trial
OTCMKTS:POSC

Positron Q1 2026 Earnings Results & Report

Positron logo
$1.64 -0.05 (-2.96%)
As of 01:48 PM Eastern

Positron reported Q1 2026 earnings on May 15, 2026. The company reported EPS of -$0.04, while revenue was $110 thousand.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes

Positron EPS Results

Actual EPS
-$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Positron Revenue Results

Actual Revenue
$110 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Positron Q1 2026 Earnings FAQ

Positron (OTCMKTS:POSC) reported earnings of -$0.04 per share for Q1 2026. The report was announced on Friday, May 15, 2026.

Positron reported revenue of $110 thousand for Q1 2026.

Positron Earnings Headlines

Positron Corp Stock Price History
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
See More Positron Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Positron? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Positron and other key companies, straight to your email.

About Positron

Positron (OTCMKTS:POSC) Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers.

The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions. The company’s publicly available information provides limited detail about its current geographic markets and leadership.

View Positron Profile